Grants for County governments - Health

This funding opportunity supports researchers in developing innovative animal models and biological resources to advance the understanding of Down syndrome and its related health conditions.

The National Cancer Institute (NCI) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the RNA Modifications Driving Oncogenesis (RNAMoDO) Initiative. It aims to promote mechanistic research in the emerging area of RNA modifications that drive oncogenesis, with a focus on the central role of RNA modifications in translational reprogramming of cancer cells. RNA modifications have been recognized to exert a substantial impact on gene expression and function and their de-regulation has been linked to the cancer phenotype. In particular, recent insights point to a crucial role for mRNA, tRNA, and rRNA modifications in translational reprogramming during tumor initiation, progression, and adaptation to therapy. However, the molecular mechanisms underlying this reshaping of the translatome caused by dynamic changes in RNA modifications, and especially the interplay between different RNA modifications within and across RNA molecules during translation, are not understood and represent the focus of this initiative. Historically, the research community has largely pursued investigations of RNA modifications by studying single RNA species and modification types. However, elucidating how dysregulation of mRNA, tRNA, and rRNA modifications reprograms translation to drive oncogenesis is not likely feasible for any single research laboratory, but will require the combination of expertise in mRNA, tRNA and rRNA biology, translational regulation, and cancer research. To stimulate progress in this emerging field, the RNAMoDO program will support collaborative research projects, preferably using an MPI structure, on how modifications in mRNA, tRNA, and rRNA molecules can drive the oncogenic process through translational reprogramming. To be responsive to the NOFO, each project will also explore the impact of interactions between modifications residing on the same or different RNA molecules during translation. This Notice of Intent to Publish (NOITP) is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in the early Fall of 2024, with an expected application due date in November 2024. The NOFO will utilize the U01 mechanism for Research Project Cooperative Agreement (Clinical Trial Not Allowed). Potential applicants are encouraged to view the presentation of this initiative to the NCI Board of Scientific Advisors (BSA), available at: (https://videocast.nih.gov/watch=54423) beginning at 1 hour, 32 minutes, 52 seconds. Presentation slides are downloadable at https://deainfo.nci.nih.gov/advisory/bsa/0324/Maas.pdf.

The Byrne Justice Assistance Grant (JAG) Washington Innovation Fund is a program designed to enhance Washington state's criminal legal system by supporting innovative, sustainable, and data-driven practices. Its overarching goals are to improve community safety, foster collaboration among various sectors, and provide support to victims and individuals involved in the criminal legal system. This aligns with a foundational mission of creating a fair and equitable criminal legal system in Washington that prioritizes these critical areas. The program draws on the Edward Byrne Memorial JAG program, a significant federal source of criminal justice funding, administered by the Bureau of Justice Assistance (BJA), which provides essential resources to state and local jurisdictions for system improvement and community advancement. The target beneficiaries of the JAG Innovation Fund include local governments and private community-based or non-profit agencies that are working to improve the criminal legal system. The program aims to impact community safety directly, enhance support for victims, and strengthen cross-sector collaboration and collective accountability within the system. Ultimately, the expected outcomes include the implementation of more effective and data-informed stewardship of criminal legal system resources, leading to a more just and safer Washington. The JAG Innovation Fund focuses on several key priorities for funding, including organizational or program capacity building, supporting new ideas, projects, or promising practices, enhancing system and community collaborations, and expanding or supplementing existing programs or practices. The program identifies nine specific Purpose Areas to allow for diverse and flexible criminal legal system improvement projects. These areas range from Planning, Evaluation and Technology Improvement to Crime Victim Programming, Support and Advocacy, Community Safety Enhancement, and Corrections, Community Corrections and Re-Entry, among others. Approximately $1,000,000 of JAG funding is dedicated to the Innovation Fund each award cycle, with individual project awards supporting proposals up to $150,000. The funding period for projects is from November 1, 2024, to December 31, 2025. To ensure accountability and community relevance, non-governmental applicants must provide one or more letters of support from a local government unit in the project's jurisdiction, explaining the proposed program's benefits to the local government agency and jurisdiction. This requirement underscores the program's strategic priority of fostering robust community and governmental partnerships as a theory of change for sustainable criminal legal system improvements.

This funding opportunity supports researchers from various fields in developing innovative methods to study brain changes over time, focusing on both healthy individuals and those with specific cognitive or emotional challenges.

This funding opportunity supports researchers exploring heart, lung, and blood diseases and sleep disorders by providing access to valuable biospecimen collections for preliminary data generation.

This grant provides financial support for senior graduate students from diverse backgrounds to complete their dissertations in aging research, promoting a more inclusive scientific workforce.

This funding opportunity supports physician-scientists with clinical doctorate degrees who are transitioning to independent research careers in non-malignant hematology, enabling them to advance their research on blood disorders.

This funding opportunity supports research projects that develop and test strategies to overcome barriers to HIV prevention for individuals who use substances, particularly focusing on marginalized groups such as women, transgender individuals, and those involved in the criminal justice system.

The grant application is for activities such as historic resources survey, National Register nominations, preservation planning, design guidelines, information/education projects, historic structures reports, conditions assessment reports, structural assessment reports, preservation plans, architectural drawings, and specifications. Cemetery projects such as cemetery resource/monument surveys, groundpenetrating radar surveys, preservation plans, master plans, or conditions assessment reports are also eligible. This grant application also supports physical “bricks and mortar” rehabilitation activities for historic sitespecific buildings, structures, monuments, and places, including cemeteries and parks. Development project applications must provide the following three items to be considered eligible for HPF grant funding: a legal description of the property, listing in the National Register of Historic Places, and previous documentation of predevelopment/planning activities associated with the resource. At the completion of a development project, a preservation agreement or covenant is required for the property

This funding opportunity supports the development of advanced bioelectronic bandages that can monitor and treat wounds in real-time, specifically targeting military medical care for combat personnel.

This grant provides funding for innovative technology development projects that aim to create new tools and methods for advancing biomedical research, focusing on prototypes that address significant technical challenges.

This funding opportunity provides resources for Arizona-based organizations to conduct integrated testing for HIV, Hepatitis C, and Syphilis, aiming to improve early detection and linkage to care in diverse community settings.

This funding opportunity supports U.S. higher education institutions and nonprofits in training predoctoral and postdoctoral researchers to advance interdisciplinary research on Alzheimer's Disease and related dementias.

This funding opportunity supports early-career researchers from diverse backgrounds in advancing their studies on Alzheimer's Disease-Related Dementias, helping them transition from mentored postdoctoral positions to independent faculty roles.

This grant provides funding to organizations that support programs helping older adults and individuals with disabilities manage chronic diseases while improving their behavioral health through education and community partnerships.

This funding opportunity provides financial support to organizations working to improve community health services in Liberia, focusing on maternal and child health, nutrition, and disease prevention in underserved areas.

The "Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH)" grant aims to support research that develops new behavioral measures and data infrastructure to improve the diagnosis, prognosis, and treatment of mental disorders.

This Notice of Funding Opportunity (NOFO) requests applications to explore human pancreatic tissues and the immune compartment for the discovery of specific signaling or processing pathways that may contribute to the asymptomatic phase of T1D, the discovery of early biomarkers of T1D pathogenesis, the development of diagnostic tools for the detection and staging of early T1D in at-risk or recently-diagnosed individuals, and/or the identification and biological validation of therapeutic targets for the development of preventative or early treatment strategies. Successful applicants will join the Consortium on Beta Cell Death and Survival (CBDS), whose mission is to better define and detect the mechanisms of beta cell stress and destruction central to the development of T1D in humans, with the long-term goal of protecting the residual beta cell mass in T1D patients as early as possible in the disease process, and of preventing the progression to autoimmunity. The CBDS is part of a collaborative research framework, the Human Islet Research Network (HIRN, https://hirnetwork.org/), whose overall mission is to support innovative and collaborative translational research to understand how human beta cells are lost in T1D, and to find innovative strategies to protect and replace functional beta cell mass in humans. This NOFO will only support studies with a primary focus on increasing our understanding of human disease biology (as opposed to rodent or other animal models). This NOFO will not accept applications proposing a clinical trial.

This funding opportunity provides up to $1 million to nonprofit organizations, educational agencies, and higher education institutions in New York State to create collaborative hubs that focus on preventing youth involvement in the justice system and improving outcomes for families and communities.

This funding opportunity supports a wide range of research projects aimed at improving the understanding, prevention, diagnosis, and treatment of Alzheimer's Disease and related dementias, particularly focusing on underserved populations and health disparities.